News & Updates

Category: APhA

APhA Opposes DEA Proposal to Reschedule Hydrocodone

May 12, 2014 Tags: APhA, DEA

Opposing DEA's proposal to reschedule hydrocodone combination products from Schedule III to Schedule II, APhA's government affairs team led the development and submission of a joint pharmacy stakeholder comment letter to the agency.

The joint pharmacy comments acknowledge the seriousness of prescription drug abuse but emphasizes that rescheduling may not have an effect on decreasing abuse and would have a negative impact on legitimate patient access to these effective pain medications.

Read more